Adsorption and Treatment of Organic Contaminants using Activated Carbon from Waste Nigerian Bamboo.

The adsorption and treatment of organic contaminants using activated carbon from waste Nigerian bamboo was investigated. Waste Nigerian bamboo was carbonized at 400oC-500oC and activated with acidat 800oC to produce granular activated carbon (GAC). Adsorption of organics from the refinery waste on the activated carbon produced was examined at 28oC. The experimental batch equilibrium data was correlated by Freundlich and Langmuir isotherms. The adsorption data fitted well into the Freundlich isotherm. Breakthrough timeof about 1.5 hours was observed for the fixed bed adsorption process. The organic concentration expressed as chemical oxygen demand (COD) was reduced from an initial value of 378 mg/l to 142 mg/l for the first hour, 143 mg/l for the second hour, 152 mg/l for the third and fourth hours, and 156 mg/l for the final hour., which also compare favorably with the refinery effluent specification of 150 mg/l Results from the study shows that waste Nigerian bamboo can be converted into high capacity adsorbent and used for the remediation of polluted industrial waste waters

The Nigeria Parkinson Disease Registry: Process, Profile, and Prospects of a Collaborative Project

BACKGROUND: Clinical disease registries are useful for quality improvement in care, benchmarking standards, and facilitating research. Collaborative networks established thence can enhance national and international studies by generating more robust samples and credible data and promote knowledge sharing and capacity building. This report describes the methodology, baseline data, and prospects of the Nigeria Parkinson Disease Registry. METHODS: This national registry was established in November 2016. Ethics approval was obtained for all sites. Basic anonymized data for consecutive cases fulfilling the United Kingdom Parkinson's Disease Brain Bank criteria (except the exclusion criterion of affected family members) are registered by participating neurologists via a secure registry website (www.parkinsonnigeria.com) using a minimal common data capture format. RESULTS: The registry had captured 578 participants from 5 of 6 geopolitical zones in Nigeria by July 2019 (72.5% men). Mean age at onset was 60.3 ± 10.7 years; median disease duration (interquartile range) was 36 months (18–60.5 months). Young‐onset disease (<50 years) represented 15.2%. A family history was documented in 4.5% and 7.8% with age at onset <50 and ≥ 50, respectively. The most frequent initial symptom was tremor (45.3%). At inclusion, 93.4% were on treatment (54.5% on levodopa monotherapy). Per‐capita direct cost for the registry was $3.37. CONCLUSIONS: This is the first published national Parkinson's disease registry in sub‐Saharan Africa. The registry will serve as a platform for development of multipronged evidence‐based policies and initiatives to improve quality of care of Parkinson's disease and research engagement in Nigeria